Prostate-Specific Antigen (PSA) Test Candidates

Physicians' recommendations for screening vary. Some encourage yearly screening for men over age 50, and some advise men who are at a higher risk for prostate cancer to begin screening at age 40 or 45. Others caution against routine screening, while still others counsel men about the risks and benefits on an individual basis and encourage men to make personal decisions about screening. Currently, Medicare provides coverage for an annual PSA test for all men age 50 and older.

Envisioneering Medical focuses resources and technology to develop equipment to aid physicians in detection, diagnosis and treatment. The TargetScan 3D imaging and targeted biopsy system offers the first real advance in prostate imaging and biopsy in over a decade. It eases any discomfort of probing during examination, as once it is place, there is no need for repositioning. The system allows a physician to generate a true solid 3D image, manipulate it, and precisely plan and undertake a multi-sample biopsy of a targeted tissue mass in the prostate. Click to learn more about TargetScan 3D or ask your physician today.